These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 9050770

  • 1. Effects of low-dose pravastatin sodium on plasma cholesterol levels and aortic atherosclerosis of heterozygous WHHL rabbits fed a low cholesterol (0.03%) enriched diet for one year.
    Harsch M, Braesen JH, Niendorf A.
    Atherosclerosis; 1997 Feb 10; 128(2):139-47. PubMed ID: 9050770
    [Abstract] [Full Text] [Related]

  • 2. Survival and cardiovascular pathology of heterozygous Watanabe heritable hyperlipidaemic rabbits treated with pravastatin and probucol on a low-cholesterol (0.03%)-enriched diet.
    Bräsen JH, Harsch M, Niendorf A.
    Virchows Arch; 1998 Jun 10; 432(6):557-62. PubMed ID: 9672198
    [Abstract] [Full Text] [Related]

  • 3. Pravastatin decreases serum lipids and vascular cholesterol deposition in Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Khachadurian AK, Shimamura T, Rozovski SJ, Ananthakrishnan R, Armenian B, Coly E, alHinai A, Martucci C, Schneider SH, Amorosa LF.
    Jpn Heart J; 1991 Sep 10; 32(5):675-85. PubMed ID: 1774829
    [Abstract] [Full Text] [Related]

  • 4. Effects of pravastatin on cholesterol metabolism of cholesterol-fed heterozygous WHHL rabbits.
    Harsch M, Gebhardt A, Reymann A, Lang G, Schliack M, Löser R, Braesen JH, Niendorf A.
    Br J Pharmacol; 1998 May 10; 124(2):277-82. PubMed ID: 9641543
    [Abstract] [Full Text] [Related]

  • 5. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits.
    Shiomi M, Ito T, Tsukada T, Yata T, Watanabe Y, Tsujita Y, Fukami M, Fukushige J, Hosokawa T, Tamura A.
    Arterioscler Thromb Vasc Biol; 1995 Nov 10; 15(11):1938-44. PubMed ID: 7583574
    [Abstract] [Full Text] [Related]

  • 6. Cholesterol-fed heterozygous Watanabe heritable hyperlipidemic rabbits: a new model for atherosclerosis.
    Atkinson JB, Hoover RL, Berry KK, Swift LL.
    Atherosclerosis; 1989 Aug 10; 78(2-3):123-36. PubMed ID: 2783197
    [Abstract] [Full Text] [Related]

  • 7. The effect of cholesterol reduction on the endothelial function and progression of atherosclerosis in WHHL rabbits.
    Kroon AA, Stalenhoef AF, Buikema H, Demacker PN, de Wilde PC, Leijten PA, van Gilst WH.
    Atherosclerosis; 1993 Nov 10; 103(2):221-30. PubMed ID: 8292097
    [Abstract] [Full Text] [Related]

  • 8. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall.
    Matsuo M, Ito F, Konto A, Aketa M, Tomoi M, Shimomura K.
    Biochim Biophys Acta; 1995 Dec 07; 1259(3):254-60. PubMed ID: 8541332
    [Abstract] [Full Text] [Related]

  • 9. Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins.
    Shiomi M, Ito T, Hirouchi Y, Enomoto M.
    Atherosclerosis; 2001 Jul 07; 157(1):75-84. PubMed ID: 11427206
    [Abstract] [Full Text] [Related]

  • 10. Pravastatin sodium, a competitive inhibitor of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases the cholesterol content of newly secreted very-low-density lipoprotein in Watanabe heritable hyperlipidemic rabbits.
    Shiomi M, Ito T.
    Metabolism; 1994 May 07; 43(5):559-64. PubMed ID: 8177044
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
    Park KY, Heo TH.
    Cardiovasc Ther; 2018 Dec 07; 36(6):e12476. PubMed ID: 30378752
    [Abstract] [Full Text] [Related]

  • 12. Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits.
    Shiomi M, Ito T, Tsukada T, Tsujita Y, Horikoshi H.
    Atherosclerosis; 1999 Feb 07; 142(2):345-53. PubMed ID: 10030386
    [Abstract] [Full Text] [Related]

  • 13. Nifedipine reduces atherogenesis in cholesterol-fed heterozygous WHHL rabbits.
    Atkinson JB, Swift LL.
    Atherosclerosis; 1990 Oct 07; 84(2-3):195-201. PubMed ID: 2282099
    [Abstract] [Full Text] [Related]

  • 14. Low-dose cerivastatin inhibits spontaneous atherogenesis in heterozygous watanabe hyper lipidemic rabbits.
    Pauletto P, Puato M, Faggin E, Sartore S.
    J Vasc Res; 2000 Oct 07; 37(3):189-94. PubMed ID: 10859477
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.